Learning objectives
- 1Identify pharmacokinetic changes caused by cardiopulmonary bypass, including hemodilution, hypothermia, and altered protein binding.
- 2Compare dosing adjustments and TCI model limitations for propofol, volatile agents, and opioids during CPB.
- 3Assess clinical strategies to optimize anesthetic depth during CPB, including monitoring and patient-specific factors.